Global post‐marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011–2022

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Neuro-Oncology

Topics

Medicine

Cancer Oncology

Dermatology

Internal Medicine

Genetics

Show all topics

DOI

10.1007/s11060-024-04682-7

License

CC-BY

Other Formats

PDF